A2ML1
Basic information
Region (hg38): 12:8822621-8887001
Previous symbols: [ "CPAMD9" ]
Links
Phenotypes
GenCC
Source:
- Noonan syndrome (Supportive), mode of inheritance: AD
- Noonan syndrome (Disputed Evidence), mode of inheritance: AD
- Noonan syndrome (Limited), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Otitis media, susceptibility to | AD | Allergy/Immunology/Infectious | Individuals may have increased susceptibility to otitis media, and awareness may allow awareness leading to prompt diagnosis and treatment of otitis media | Allergy/Immunology/Infectious | 26121085 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the A2ML1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 281 | 10 | 296 | |||
missense | 603 | 35 | 17 | 655 | ||
nonsense | 39 | 41 | ||||
start loss | 0 | |||||
frameshift | 30 | 33 | ||||
inframe indel | 9 | |||||
splice donor/acceptor (+/-2bp) | 27 | 28 | ||||
splice region | 28 | 35 | 3 | 66 | ||
non coding | 10 | 170 | 157 | 337 | ||
Total | 0 | 1 | 723 | 488 | 187 |
Variants in A2ML1
This is a list of pathogenic ClinVar variants found in the A2ML1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-8822636-T-C | not specified | Likely benign (Jan 16, 2018) | ||
12-8822660-T-A | not specified • Otitis media, susceptibility to | Benign/Likely benign (Jan 20, 2024) | ||
12-8822661-C-T | Otitis media, susceptibility to • Otitis media | Likely pathogenic (Oct 30, 2018) | ||
12-8822664-C-G | Uncertain significance (Nov 10, 2020) | |||
12-8822672-A-G | not specified | Benign/Likely benign (Jul 09, 2023) | ||
12-8822677-T-C | not specified | Uncertain significance (Mar 15, 2024) | ||
12-8822680-T-A | not specified | Uncertain significance (Sep 23, 2021) | ||
12-8822687-A-G | Likely benign (Feb 12, 2020) | |||
12-8822695-C-A | not specified | Uncertain significance (Mar 24, 2024) | ||
12-8822701-C-A | Uncertain significance (Oct 16, 2020) | |||
12-8822701-CAGA-C | Uncertain significance (Jul 10, 2022) | |||
12-8822703-G-A | not specified | Uncertain significance (May 15, 2023) | ||
12-8822706-G-A | not specified | Likely benign (Nov 02, 2022) | ||
12-8822712-C-A | Uncertain significance (Dec 24, 2021) | |||
12-8822712-C-G | not specified | Conflicting classifications of pathogenicity (Jan 22, 2024) | ||
12-8822713-C-T | not specified | Uncertain significance (Dec 16, 2019) | ||
12-8822714-G-A | Uncertain significance (Apr 19, 2023) | |||
12-8822714-G-C | Uncertain significance (Dec 11, 2019) | |||
12-8822722-T-C | Likely benign (Aug 24, 2023) | |||
12-8823009-A-G | Benign (Jun 19, 2018) | |||
12-8823168-T-G | Likely benign (Nov 15, 2021) | |||
12-8823173-CT-C | not specified | Conflicting classifications of pathogenicity (Mar 01, 2022) | ||
12-8823178-A-G | not specified • A2ML1-related disorder | Benign/Likely benign (Nov 22, 2023) | ||
12-8823186-T-TA | Uncertain significance (Jan 29, 2024) | |||
12-8823187-A-G | not specified | Conflicting classifications of pathogenicity (Sep 18, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
A2ML1 | protein_coding | protein_coding | ENST00000299698 | 35 | 64530 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.61e-34 | 0.0208 | 112756 | 336 | 11707 | 124799 | 0.0495 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.327 | 766 | 792 | 0.967 | 0.0000414 | 9472 |
Missense in Polyphen | 183 | 202.78 | 0.90244 | 2583 | ||
Synonymous | -0.0672 | 316 | 314 | 1.00 | 0.0000177 | 2835 |
Loss of Function | 1.91 | 63 | 81.6 | 0.772 | 0.00000397 | 960 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.102 | 0.102 |
Ashkenazi Jewish | 0.0663 | 0.0666 |
East Asian | 0.00490 | 0.00491 |
Finnish | 0.0334 | 0.0332 |
European (Non-Finnish) | 0.0555 | 0.0552 |
Middle Eastern | 0.00490 | 0.00491 |
South Asian | 0.0700 | 0.0693 |
Other | 0.0568 | 0.0572 |
dbNSFP
Source:
- Function
- FUNCTION: Is able to inhibit all four classes of proteinases by a unique 'trapping' mechanism. This protein has a peptide stretch, called the 'bait region' which contains specific cleavage sites for different proteinases. When a proteinase cleaves the bait region, a conformational change is induced in the protein which traps the proteinase. The entrapped enzyme remains active against low molecular weight substrates (activity against high molecular weight substrates is greatly reduced). Following cleavage in the bait region a thioester bond is hydrolyzed and mediates the covalent binding of the protein to the proteinase (By similarity). Displays inhibitory activity against chymotrypsin, papain, thermolysin, subtilisin A and, to a lesser extent, elastase but not trypsin. May play an important role during desquamation by inhibiting extracellular proteases. {ECO:0000250|UniProtKB:P01023, ECO:0000269|PubMed:16298998}.;
Recessive Scores
- pRec
- 0.0833
Intolerance Scores
- loftool
- 0.960
- rvis_EVS
- 2.42
- rvis_percentile_EVS
- 98.53
Haploinsufficiency Scores
- pHI
- 0.0600
- hipred
- N
- hipred_score
- 0.145
- ghis
- 0.382
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.155
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Gene ontology
- Biological process
- negative regulation of endopeptidase activity;regulation of endopeptidase activity
- Cellular component
- extracellular space;extracellular exosome
- Molecular function
- serine-type endopeptidase inhibitor activity;peptidase inhibitor activity